Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Subscribe To Our Newsletter & Stay Updated
